Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-12,595
Closed -$560K 159
2017
Q4
$560K Buy
12,595
+1,663
+15% +$76.8K 0.04% 281
2017
Q3
$547K Sell
10,932
-2,399
-18% -$122K 0.04% 292
2017
Q2
$718K Buy
13,331
+1,981
+17% +$106K 0.06% 230
2017
Q1
$595K Buy
11,350
+208
+2% +$10.6K 0.05% 234
2016
Q4
$539K Buy
11,142
+1,860
+20% +$91.9K 0.05% 218
2016
Q3
$500K Buy
+9,282
New +$509K 0.05% 223

Other funds holding GSK

IFC Holdings's GSK Position: Q1 2018 in Review

IFC Holdings sold out of GSK (GSK) in Q1 2018, closing a stake of 12,595 shares — an estimated $560K sold.

IFC Holdings first reported a position in GSK in Q3 2016 and held it in 6 quarters. The position peaked at $718K in Q2 2017. 779 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

  • IFC Holdings reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
  • IFC Holdings sold 12,595 GSK shares in Q1 2018, an estimated $560K.
  • IFC Holdings first reported a position in GSK in Q3 2016 and held it in 6 quarters.
  • IFC Holdings's GSK position peaked at $718K in Q2 2017.
  • 779 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on IFC Holdings's 13F filing for Q1 2018.